Atlas Trials

Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes

Clinical trial NCT05054842 · UNKNOWN

Trial details

NCT number
NCT05054842
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2021-12-06
Primary completion
2023-12-01
Enrollment
174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.